187 related articles for article (PubMed ID: 21644048)
21. Neutrophil elastase treated dendritic cells promote the generation of CD4(+)FOXP3(+) regulatory T cells in vitro.
Tateosian NL; Reiteri RM; Amiano NO; Costa MJ; Villalonga X; Guerrieri D; Maffía PC
Cell Immunol; 2011; 269(2):128-34. PubMed ID: 21477798
[TBL] [Abstract][Full Text] [Related]
22. Quantification and phenotype of regulatory T cells in rheumatoid arthritis according to disease activity score-28.
Sempere-Ortells JM; Pérez-García V; Marín-Alberca G; Peris-Pertusa A; Benito JM; Marco FM; Zubcoff JJ; Navarro-Blasco FJ
Autoimmunity; 2009; 42(8):636-45. PubMed ID: 19886735
[TBL] [Abstract][Full Text] [Related]
23. The ex vivo induction of human CD103⁺ CD25hi Foxp3⁺ CD4⁺ and CD8⁺ Tregs is IL-2 and TGF-β1 dependent.
Gunnlaugsdottir B; Maggadottir SM; Skaftadottir I; Ludviksson BR
Scand J Immunol; 2013 Feb; 77(2):125-34. PubMed ID: 23126599
[TBL] [Abstract][Full Text] [Related]
24. The regulatory function of umbilical cord blood CD4(+) CD25(+) T cells stimulated with anti-CD3/anti-CD28 and exogenous interleukin (IL)-2 or IL-15.
Lee CC; Lin SJ; Cheng PJ; Kuo ML
Pediatr Allergy Immunol; 2009 Nov; 20(7):624-32. PubMed ID: 19302176
[TBL] [Abstract][Full Text] [Related]
25. Insufficient increment of CD4+CD25+ regulatory T cells after stimulation in vitro with allergen in allergic asthma.
Wang LH; Lin YH; Yang J; Guo W
Int Arch Allergy Immunol; 2009; 148(3):199-210. PubMed ID: 18849611
[TBL] [Abstract][Full Text] [Related]
26. Aurintricarboxylic acid promotes the conversion of naive CD4+CD25- T cells into Foxp3-expressing regulatory T cells.
Lim DG; Park YH; Kim SE; Kim YH; Park CS; Kim SC; Park CG; Han DJ
Int Immunol; 2011 Sep; 23(9):583-92. PubMed ID: 21750147
[TBL] [Abstract][Full Text] [Related]
27. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
Ahn JS; Krishnadas DK; Agrawal B
Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
[TBL] [Abstract][Full Text] [Related]
28. In vitro human TGF-beta treatment converts CD4(+)CD25(-) T cells into induced T regulatory like cells.
Shanmugasundaram R; Selvaraj RK
Vet Immunol Immunopathol; 2010 Sep; 137(1-2):161-5. PubMed ID: 20684851
[TBL] [Abstract][Full Text] [Related]
29. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
Pyzik M; Piccirillo CA
J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
[TBL] [Abstract][Full Text] [Related]
30. Role of interleukin-10 and transforming growth factor beta 1 in otitis media with effusion.
Zhao SQ; Li J; Liu H; Zhang QG; Wang Y; Han DM
Chin Med J (Engl); 2009 Sep; 122(18):2149-54. PubMed ID: 19781301
[TBL] [Abstract][Full Text] [Related]
31. Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment.
You S; Leforban B; Garcia C; Bach JF; Bluestone JA; Chatenoud L
Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6335-40. PubMed ID: 17389382
[TBL] [Abstract][Full Text] [Related]
32. Increased CD4(+) CD69(+) CD25(-) T cells in patients with hepatocellular carcinoma are associated with tumor progression.
Zhu J; Feng A; Sun J; Jiang Z; Zhang G; Wang K; Hu S; Qu X
J Gastroenterol Hepatol; 2011 Oct; 26(10):1519-26. PubMed ID: 21557772
[TBL] [Abstract][Full Text] [Related]
33. Immunosuppressive effects of rat mesenchymal stem cells: involvement of CD4+CD25+ regulatory T cells.
Ye Z; Wang Y; Xie HY; Zheng SS
Hepatobiliary Pancreat Dis Int; 2008 Dec; 7(6):608-14. PubMed ID: 19073406
[TBL] [Abstract][Full Text] [Related]
34. [Influence of anti-ICOS antibody on quantity and function of CD4(+);CD25(+);Foxp3(+);Treg from lymph and blood of rats with bronchial asthma].
Zhao L; Feng XB; Wang YS; Cui QQ; Cao YY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Oct; 28(10):1029-32. PubMed ID: 23046932
[TBL] [Abstract][Full Text] [Related]
35. TGF-beta1 production by CD4+ CD25+ regulatory T cells is not essential for suppression of intestinal inflammation.
Kullberg MC; Hay V; Cheever AW; Mamura M; Sher A; Letterio JJ; Shevach EM; Piccirillo CA
Eur J Immunol; 2005 Oct; 35(10):2886-95. PubMed ID: 16180248
[TBL] [Abstract][Full Text] [Related]
36. Expression of intracellular transforming growth factor-beta1 in CD4+CD25+ cells in patients with systemic lupus erythematosus.
Lu LY; Chu JJ; Lu PJ; Sung PK; Hsu CM; Tseng JC
J Microbiol Immunol Infect; 2008 Apr; 41(2):165-73. PubMed ID: 18473105
[TBL] [Abstract][Full Text] [Related]
37. Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission.
Abdulahad WH; Stegeman CA; van der Geld YM; Doornbos-van der Meer B; Limburg PC; Kallenberg CG
Arthritis Rheum; 2007 Jun; 56(6):2080-91. PubMed ID: 17530650
[TBL] [Abstract][Full Text] [Related]
38. Regulatory T cells in patients with systemic lupus erythematosus.
Alvarado-Sánchez B; Hernández-Castro B; Portales-Pérez D; Baranda L; Layseca-Espinosa E; Abud-Mendoza C; Cubillas-Tejeda AC; González-Amaro R
J Autoimmun; 2006 Sep; 27(2):110-8. PubMed ID: 16890406
[TBL] [Abstract][Full Text] [Related]
39. Regulatory T cells (CD4(+)CD25(bright)FoxP3(+)) expansion in systemic sclerosis correlates with disease activity and severity.
Slobodin G; Ahmad MS; Rosner I; Peri R; Rozenbaum M; Kessel A; Toubi E; Odeh M
Cell Immunol; 2010; 261(2):77-80. PubMed ID: 20096404
[TBL] [Abstract][Full Text] [Related]
40. [Expressions of CD4+ CD25(high) regulatory T cells, TGF-beta 1 and COX-2 in the peripheral blood of prostate cancer patients].
Xia TL; Liu T; Wu ZQ; Zhang HB; Yang M; Liu SY; He ZB; Li LY
Zhonghua Nan Ke Xue; 2011 Oct; 17(10):888-93. PubMed ID: 22049790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
